Trust is a Two-Way Street

Recent news headlines have spotlighted how unethical and irresponsible behavior on the part of pharma companies and their agencies can breach public trust and negatively impact patient lives. As a respect-centered organization, trust is one of our five core values. It’s imperative to partner with those who match your values – or be prepared to walk away. V2V President Dan Rehal shares a story about trust in this short video.

ABOUT THE AUTHOR

Picture of Daniel J. Rehal

Daniel J. Rehal

As President of Vision2Voice, Daniel thoroughly understands the pharmaceutical industry from the ground floor up. By ascending the ranks at Merck to his global responsibilities at Takeda, Dan has significant experience in both marketing and sales roles supporting a multitude of pharmaceutical brands as an award-winning Sales Representative, Training Manager, District Manager, Senior Product Manager, and Marketing Director.

Recent Posts

Crowd of KOLs and DOLs

DOLs: A New Frontier

Whether you call them Key Opinion Leaders (KOLs) or Key External Experts (KEEs), success in the pharmaceutical space has always started with one essential task:...

Read More
Scientist in googles

Industry Happenings – October 2026

Learn how major industry trends are influencing the future of biopharma, including patent expiration challenges, evolving regulatory pathways, and emerging therapeutic targets that are attracting...

Read More
Magnifying glass inspecting men in suits

Industry Happenings -September 2026

FDA policy, shifting R&D priorities, and heightened oversight of overseas trials are shaping the future of drug development. Don’t miss the latest in BioPharma! Source:...

Read More